Stay updated on Palovarotene for MO: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Palovarotene for MO: Efficacy & Safety Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision indicator updated from v3.5.2 to v3.5.3, signaling a minor site update to the page. No study data or details are affected by this change.
    Difference
    0.1%
    Check dated 2026-04-29T08:42:52.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The displayed revision version at the bottom of the page was updated from v3.5.0 to v3.5.2. No other study details appear to have changed.
    Difference
    0.0%
    Check dated 2026-04-21T01:14:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Publications and record history entries were added; core study details and locations remain unchanged.
    Difference
    0.1%
    Check dated 2026-04-14T00:23:48.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The MO-Ped trial (NCT03442985) was terminated early to analyze accumulated data and evaluate the future of palovarotene in MO.
    Difference
    0.1%
    Check dated 2026-04-06T20:13:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    This update appears to be a formatting/layout adjustment with no changes to core study content (outcomes, eligibility criteria, or locations).
    Difference
    0.1%
    Check dated 2026-03-30T10:32:27.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-23T04:54:14.000Z thumbnail image

Stay in the know with updates to Palovarotene for MO: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Palovarotene for MO: Efficacy & Safety Clinical Trial page.